This trial is active, not recruiting.

Condition cancer
Sponsor Optivasive Ltd.
Start date March 2008
Trial size 50 participants
Trial identifier NCT00791609, OpVe-HI-08-001


Feasibility of accurate differentiation between malignant and benign tissue using the FOSTI device on surgically removed tissue

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case-only
Time perspective cross-sectional

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Subjects of all ages. - Subject is able, agree and sign the Informed Consent Form. Exclusion Criteria: - Subject has any conditions, which precludes compliance with study

Additional Information

Official title Evaluation the Feasibility of the FOSTI Device Accurately and in a Real Time Way to Differentiate Malignant From Benign Tissue (Performed ex Vivo) in Cancer Surgery
Description Characterization of the optical fiber sensor's interaction with the tissue. Creating a database of tissue lesions and their 'optical signature' (lesion classifier). Optimization of the FOSTI device by minimizing the false-positive and false-negative results.
Trial information was received from ClinicalTrials.gov and was last updated in November 2008.
Information provided to ClinicalTrials.gov by Optivasive Ltd..